Nephrology Medical News about RCC

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Current state of systemic therapy of metastatic renal cell carcinoma
Der Urologe, 08/13/09

Merseburger AS et al. – Sunitinib and sorafenib as multikinase inhibitors, everolimus and temsirolimus as mTOR inhibitors, and bevacizumab as an antibody against VEGF in combination with interferon–alpha (IFN–alpha). The following article will give an overview of the currently available substances and critically discuss therapy plans and future trends.

<< Previous
Long-term effect of modification of dietary protein intake on the...

Next >>
Retroperitoneal Laparoscopic and Open Radical Nephrectomy for T1...

Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma
Journal of Korean Medical Science, 11/16/09 Relevance Score: 84%

Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era
European Urology, 11/03/09 Relevance Score: 84%

Population-based survey of cancer risks in chromosome 3 translocation carriers
Genes, Chromosomes and Cancer, 10/28/09 Relevance Score: 84%

Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Cancer Research, 10/20/09 Relevance Score: 84%

Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09 Relevance Score: 84%